The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka ; volume:10 ; number:1 ; day:10 ; month:8 ; year:2017 ; pages:1-5 ; date:12.2017
BMC Research Notes / Biomed Central; 10, Heft 1 (10.8.2017), 1-5, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Sirisena, Nirmala Dushyanthi
- Beteiligte Personen und Organisationen
-
Deen, Kemal
Mandawala, Dayupathi Eranda Nipunika
Herath, Pumindu
Dissanayake, Vajira Harshadeva Weerabaddana
SpringerLink (Online service)
- DOI
-
10.1186/s13104-017-2731-5
- URN
-
urn:nbn:de:1111-2017102619014
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sirisena, Nirmala Dushyanthi
- Deen, Kemal
- Mandawala, Dayupathi Eranda Nipunika
- Herath, Pumindu
- Dissanayake, Vajira Harshadeva Weerabaddana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
KRAS and BRAF Concomitant Mutations in a Patient with Metastatic Colon Adenocarcinoma: An Interesting Case Report
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
KRAS mutations in squamous cell carcinomas of the lung
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Predictive role of [18F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients
Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS G12D or KRAS G12V mutations
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
KRAS and BRAF Concomitant Mutations in a Patient with Metastatic Colon Adenocarcinoma: An Interesting Case Report
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
KRAS mutations in squamous cell carcinomas of the lung
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Predictive role of [18F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients
Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS G12D or KRAS G12V mutations
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients
KRAS and BRAF Concomitant Mutations in a Patient with Metastatic Colon Adenocarcinoma: An Interesting Case Report
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
KRAS mutations in squamous cell carcinomas of the lung
Advances in KRAS mutation inhibition in metastatic colorectal cancer
Predictive role of [18F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients
Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS G12D or KRAS G12V mutations
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Molecular epidemiology and diagnostics of KRAS mutations in human cancer